Oncternal Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2000
Net Income	-39.48	-44.17	-31.33	-17.23	-34.19	-6.58	-30.44	-17.72	-18.7	-39.41	Upgrade
Depreciation & Amortization	0.17	0.18	0.17	0.15	0.09	0	0.05	0.03	0.04	0.1	Upgrade
Share-Based Compensation	7.5	7.43	5.88	1.56	0.51	0.19	3.15	2.96	2.62	4.43	Upgrade
Other Operating Activities	-0.36	-0.14	-1.3	-1.98	16.84	-1.03	3.78	-6.04	-4	6.12	Upgrade
Operating Cash Flow	-32.16	-36.7	-26.59	-17.5	-16.75	-7.42	-23.46	-20.78	-20.04	-28.76	Upgrade
Capital Expenditures	0	0	0	0	0	0	-0	-0.09	-0	-0.01	Upgrade
Acquisitions	0	0	0	0	18.29	0	0	0	0	0	Upgrade
Change in Investments	0.65	-26.5	0	0	0	0	-15.12	2.24	16.22	-31.22	Upgrade
Other Investing Activities	-	-	-	-	-2.16	-	-	-	-	-	Upgrade
Investing Cash Flow	0.65	-26.5	0	0	16.14	0	-15.13	2.15	16.21	-31.22	Upgrade
Share Issuance / Repurchase	1.07	9.58	0.62	113.88	0.02	0	45.65	13.69	0	63.95	Upgrade
Debt Issued / Paid	0	0	0	0.3	0	0	0	0	0	-0	Upgrade
Other Financing Activities	-	-	-	-	-	17.87	-0.16	-0.21	-	-0.62	Upgrade
Financing Cash Flow	1.07	9.58	0.62	114.18	0.02	17.87	45.49	13.48	0	63.33	Upgrade
Net Cash Flow	-30.45	-53.62	-25.97	96.69	-0.59	10.46	6.91	-5.15	-3.82	3.35	Upgrade
Free Cash Flow	-32.16	-36.7	-26.59	-17.5	-16.75	-7.42	-23.46	-20.87	-20.04	-28.76	Upgrade
Free Cash Flow Margin	-4097.32%	-2463.36%	-616.20%	-518.37%	-690.56%	-294.21%	-	-	-	-	Upgrade
Free Cash Flow Per Share	-10.94	-13.96	-10.78	-17.23	-32.42	-41.31	-188.33	-200.66	-199.87	-492.25	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).